Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer

BACKGROUND: Pertuzumab increases the rate of pathological complete response in the preoperative context and increases overall survival among patients with metastatic disease when it is added to trastuzumab and chemotherapy for the treatment of human epidermal growth factor receptor 2 (HER2)–positive...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:N Engl J Med
Main Authors: von Minckwitz, Gunter, Procter, Marion, de Azambuja, Evandro, Zardavas, Dimitrios, Benyunes, Mark, Viale, Giuseppe, Suter, Thomas, Arahmani, Amal, Rouchet, Nathalie, Clark, Emma, Knott, Adam, Lang, Istvan, Levy, Christelle, Yardley, Denise A., Bines, Jose, Gelber, Richard D., Piccart, Martine, Baselga, Jose
Format: Artigo
Sprog:Inglês
Udgivet: 2017
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5538020/
https://ncbi.nlm.nih.gov/pubmed/28581356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1703643
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker